Indium in-111 Oxyquinoline: uses, dosing, side effects & brands
Indium in-111 Oxyquinoline is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Liquid · Solution
- Sold as
- Indium in 111 Oxyquinoline
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
How indium in-111 oxyquinoline is dosed
From the FDA label for Indium in 111 Oxyquinoline (application NDA019044). Other indium in-111 oxyquinoline products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
The recommended adult (70 kg) dose of indium In 111 oxyquinoline labeled autologous leukocytes is 7.4 to 18.5 MBq, 200 to 500 µCi. Indium In 111 Oxyquinoline Solution is intended for the radiolabeling of autologous leukocytes. The indium In 111 oxyquinoline labeled autologous leukocytes are administered intravenously. Imaging is recommended at approximately 24 hours post injection. Typically, anterior and posterior views of the chest, abdomen and pelvis should be obtained with other views as required. Aseptic procedures and a shielded syringe should be employed in the withdrawal of Indium In 111 Oxyquinoline Solution from the vial. Similar procedures should be employed during the labeling procedure and the administration of the labeled leukocytes to the patient. The user should wear waterproof gloves during the entire procedure. The patient's dose should be measured by a suitable radioactivity calibration system immediately before administration. At this time, the leukocyte preparation should be checked for gross clumping and red blood cell contamination.
Indium in-111 Oxyquinoline side effects
Sensitivity reactions (urticaria) have been reported. The presence of fever may mask pyrogenic reactions from indium In 111 oxyquinoline labeled leukocytes. The possibility of delayed adverse reactions has not been studied.
Who shouldn’t take indium in-111 oxyquinoline
None known.
Every indium in-111 oxyquinoline product we track (1)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
Only one: Indium in 111 Oxyquinoline.
What people report to the FDA about indium in-111 oxyquinoline
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 5 reports naming indium in-111 oxyquinoline, and the FDA flagged 60% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- abasia1 reports
- abdominal abscess1 reports
- angiopathy1 reports
- arthralgia1 reports
- bronchospasm1 reports
- burning sensation1 reports
- cardio-respiratory arrest1 reports
- cyanosis1 reports
Read these as a signal, not a rate. A report does not mean indium in-111 oxyquinoline caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved July 25, 2026.
Related calculators
Frequently asked questions
What is indium in-111 oxyquinoline?
Indium In 111 Oxyquinoline (oxine) Solution is a diagnostic radiopharmaceutical intended for radiolabeling autologous leukocytes. It is supplied as a sterile, non-pyrogenic, isotonic aqueous solution with a pH range of 6.5 to 7.5 [sodium hydroxide and hydrochloric acid may be used to adjust the pH]. Each mL of the solution contains 37 MBq, 1 mCi of indium In 111 [no carrier added, >1.85 GBq/mcg indium (>50 mCi/mcg indium)] at calibration time, 50 mcg oxyquinoline, 100 mcg polysorbate 80, and 6 mg of HEPES (N-2-hydroxyethyl-piperazine-N'-2-ethane sulfonic acid) buffer in 0.75% Sodium Chloride Solution. The drug is intended to be used as a single-dose vial and contains no bacteriostatic agent. The radionuclidic impurity limit for indium 114m is not greater than 37 kBq, 1 µCi of indium 114m per 37 MBq, 1 mCi of indium In 111 at the time of calibration. The radionuclidic composition at expiration time is not less than 99.75% of indium In 111 and not more than 0.25% of indium In 114m/114.
Can you take indium in-111 oxyquinoline with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run indium in-111 oxyquinoline against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What forms does indium in-111 oxyquinoline come in?
Across the brands we track, indium in-111 oxyquinoline is currently marketed as liquid and solution, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic indium in-111 oxyquinoline?
We do not currently list a generic-labelled indium in-111 oxyquinoline product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Indium in-111 Oxyquinoline: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/indium-in-111-oxyquinoline
- MLA
- “Indium in-111 Oxyquinoline: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/indium-in-111-oxyquinoline.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for indium in-111 oxyquinoline on DailyMed (NIH) ↗.